- Cladribine - mechanism of action2017 | First Faculty of Medicine
- Long-term management of oral cladribine treatment in multiple sclerosis2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Treatment of multiple sclerosis with oral cladribine: results of clinical trials2017 | First Faculty of Medicine
- Oral cladribine and multiple sclerosis - efficacy and safety data update2019 | Faculty of Medicine in Pilsen
- Oral cladribine in the treatment of multiple sclerosis - data from the national registry ReMuS(R) registry2021 | Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Komentář: Post hoc analýza studie CLARITY - účinnost perorálně podávaného kladribinu u pacientů s vysokou aktivitou relabující-remitující RS2018 | First Faculty of Medicine
- Komentář ke studii (Dlouhodobý vliv kladribinu v tabletové formě na aktivitu relaps-remitentní roztroušené sklerózy hodnocenou pomocí magnetické rezonance - studie CLARITY Extension)2018 | Publication without faculty affiliation
- Lymphoma-like course in aggressive adult multisystem Langerhans cell histiocytosis and the benefit of PET/CT imaging in evaluation of diffuse metabolic activity of lung parenchyma2010 | Second Faculty of Medicine
- Komentář panelu odborníků2022 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Komentář ke studii2021 | First Faculty of Medicine
- The significance of clofarabine in the therapy of adult patient with acute myeloid leukemia2012 | Faculty of Medicine in Hradec Králové
- Chemotherapy, radiotherapy and surgery in chronic lymphocytic leukemia treatment2010 | Third Faculty of Medicine
- Experimental therapy of B-cell Non-Hodgkin's lymphonasPublication without faculty affiliation